A

Amphivena Therapeutics Inc.

14 employees

Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2012

Funding rounds raised

Total raised

$62M

from 10 investors over 10 rounds

A

Amphivena Therapeutics Inc. raised $62M on September 24, 2019

Investors: Industrial Investors Group, 凯泰资本, MPM Capital, Newton Investment Management, +ND Capital, Tekla Capital Management, Korys, Qiming Venture Partners and Solasta Ventures

A

Amphivena Therapeutics Inc. raised $14M on July 15, 2013

Investors: Janssen Biotech, Inc.

FAQ